Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hitoshi Kashiwagi"'
Autor:
Yuki, Sato, Yoh, Takekuma, Takayuki, Daisho, Hitoshi, Kashiwagi, Shungo, Imai, Mitsuru, Sugawara
Publikováno v:
Biological and Pharmaceutical Bulletin. 45:421-428
It is important to select appropriate antibiotics for infection control. Linezolid and tedizolid are newly developed and synthesized oxazolidinone antibacterial agents. It has been pointed out that there is a relationship between a high plasma concen
Autor:
Kenji Momo, Yoh Takekuma, Yuki Sato, Mitsuru Sugawara, Hiromitsu Oki, Hitoshi Kashiwagi, Yasuyuki Nasuhara, Shungo Imai, Takayuki Miyai
Publikováno v:
Biological & pharmaceutical bulletin. 44(10):1499-1505
A major adverse effect of benzbromarone is hepatotoxicity. Therefore, periodic liver function tests are required at least for the first 6 months of benzbromarone administration. However, it is not clear whether the relevant blood tests are implemente
Autor:
Takayuki Miyai, Shungo Imai, Eri Yoshimura, Hitoshi Kashiwagi, Yuki Sato, Hidefumi Ueno, Yoh Takekuma, Mitsuru Sugawara
Publikováno v:
Biologicalpharmaceutical bulletin. 45(9)
In therapeutic drug monitoring of vancomycin (VCM), the area under the concentration-time curve (AUC) is related to clinical efficacy and toxicity. Determining the maintenance for patient is necessary since VCM concentrations are affected by factors
Autor:
Shungo Imai, Tsuyoshi Aoyama, Yoh Takekuma, Hitoshi Kashiwagi, Yuki Sato, Hiroki Kuriyama, Mitsuru Sugawara
Publikováno v:
Biological & pharmaceutical bulletin. 44(8):1101-1110
Dasatinib is a first- line pharmacotherapeutic treatment for chronic myeloid leukemia (CML). It is more effective than traditional treatments but causes adverse effects such as pleural effusion that limits its effective treatment cycle. Since pleural
Autor:
Kenji Momo, Yoh Takekuma, Shinsuke Yamashita, Mitsuru Sugawara, Yuki Sato, Shungo Imai, Hitoshi Kashiwagi
Publikováno v:
Biological & pharmaceutical bulletin. 44(8):1151-1155
Olanzapine is effective for schizophrenia management; however, it is contraindicated in diabetes patients. In addition, olanzapine is useful for treating nausea and vomiting, such as in the case of chemotherapy-induced nausea and vomiting (CINV). The
Autor:
Ayako Mori, Izumi Kato, Hitoshi Kashiwagi, Shungo Imai, Katsuya Narumi, Yuki Sato, Ayako Furugen, Yuma Yamada, Masaki Kobayashi
Publikováno v:
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 142(6)
With the coronavirus disease 2019 pandemic, businesses are rapidly expanding their online practices, and the online medical care system has been established and is growing. The field of pharmacy education is also looking for ways to conduct practical
Publikováno v:
Biological and Pharmaceutical Bulletin. 44:448-452
Antibiotic-associated diarrhea (AAD) is a typical side effect of antibiotic treatment, especially in children. Amoxicillin (AMPC) and amoxicillin/clavulanate (AMPC/CVA) are associated with high risk of AAD; however, these antibiotics are important in
Publikováno v:
International Journal of Clinical Pharmacy. 42:1369-1373
Background The concurrent use of nonsteroidal anti-inflammatory drugs, renin-angiotensin-aldosterone system blockers, and diuretics, known as a "triple-whammy," is related to the occurrence of acute kidney injury. However, there are few reports regar
Publikováno v:
Biologicalpharmaceutical bulletin. 43(10)
The anti-inflammatory agent colchicine may cause toxic effects such as rhabdomyolysis, pancytopenia, and acute respiratory distress syndrome in cases of overdose and when patients have renal or liver impairment. As colchicine is a substrate for CYP3A